Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Strnad

Showing results (21-30 of 229) with videos related to

Pageof 23
Sort By:
Gastroenterology|December 9, 2024
ReplyVirginia C Clark, Pavel Strnad, Thomas Schluep
Journal of Cell Science|October 3, 2002
Induction of rapid and reversible cytokeratin filament network remodeling by inhibition of tyrosine phosphatasesPavel Strnad, Reinhard Windoffer, Rudolf E Leube
The New England Journal of Medicine|April 9, 2020
Alpha<sub>1</sub>-Antitrypsin DeficiencyPavel Strnad, Noel G McElvaney, David A Lomas
Hepatology Communications|April 14, 2025
Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicineMalin Fromme, Fabienne Klebingat, Paul Ellis, et al.
Nature Reviews. Gastroenterology & Hepatology|December 8, 2016
Liver - guardian, modifier and target of sepsisPavel Strnad, Frank Tacke, Alexander Koch, et al.
The American Journal of Gastroenterology|May 20, 2020
Response to Diao et alStephen R Atkinson, Mark R Thursz, Pavel Strnad
Expert Review of Gastroenterology & Hepatology|April 12, 2011
The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthfulAgnes Molnar, Johannes Haybaeck, Carolin Lackner, et al.
The American Journal of Gastroenterology|July 4, 2020
Response to Sainath et alStephen R Atkinson, Mark R Thursz, Pavel Strnad
Journal of Hepatology|December 3, 2014
Reply to: "Hepatic hepcidin expression is decreased in cirrhosis and HCC"Mariia Lunova, Christian Trautwein, Pavel Strnad, et al.
Annals of Hepatology|October 24, 2025
Alpha-1 antitrypsin Pi*MZ variant increases the risk of liver disease progression in MASLD and MASHBradley Jermy, Jack Brownrigg, Pavel Strnad, et al.
Pageof 23

Showing results (21-30 of 229) with videos related to

Sort By:
Pageof 23
Gastroenterology|December 9, 2024
ReplyVirginia C Clark, Pavel Strnad, Thomas Schluep
Journal of Cell Science|October 3, 2002
Induction of rapid and reversible cytokeratin filament network remodeling by inhibition of tyrosine phosphatasesPavel Strnad, Reinhard Windoffer, Rudolf E Leube
The New England Journal of Medicine|April 9, 2020
Alpha<sub>1</sub>-Antitrypsin DeficiencyPavel Strnad, Noel G McElvaney, David A Lomas
Hepatology Communications|April 14, 2025
Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicineMalin Fromme, Fabienne Klebingat, Paul Ellis, et al.
Nature Reviews. Gastroenterology & Hepatology|December 8, 2016
Liver - guardian, modifier and target of sepsisPavel Strnad, Frank Tacke, Alexander Koch, et al.
The American Journal of Gastroenterology|May 20, 2020
Response to Diao et alStephen R Atkinson, Mark R Thursz, Pavel Strnad
Expert Review of Gastroenterology & Hepatology|April 12, 2011
The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthfulAgnes Molnar, Johannes Haybaeck, Carolin Lackner, et al.
The American Journal of Gastroenterology|July 4, 2020
Response to Sainath et alStephen R Atkinson, Mark R Thursz, Pavel Strnad
Journal of Hepatology|December 3, 2014
Reply to: "Hepatic hepcidin expression is decreased in cirrhosis and HCC"Mariia Lunova, Christian Trautwein, Pavel Strnad, et al.
Annals of Hepatology|October 24, 2025
Alpha-1 antitrypsin Pi*MZ variant increases the risk of liver disease progression in MASLD and MASHBradley Jermy, Jack Brownrigg, Pavel Strnad, et al.
Pageof 23